Clinical Trial Update: A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated efficacy and safety of two topical calcipotriol formulations in adults with mild to moderate plaque psoriasis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Calcipotriol (calcipotriol)

Snippet

Sponsor: Cadila Pharnmaceuticals | Conditions: Mild to Moderate Plaque Psoriasis | Phase 3 | Status: COMPLETED